1. Home
  2. TACT vs XBIT Comparison

TACT vs XBIT Comparison

Compare TACT & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransAct Technologies Incorporated

TACT

TransAct Technologies Incorporated

HOLD

Current Price

$4.90

Market Cap

58.5M

Sector

Technology

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.31

Market Cap

69.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TACT
XBIT
Founded
1996
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.5M
69.8M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
TACT
XBIT
Price
$4.90
$2.31
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
16.9K
28.8K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
87.88
N/A
EPS
0.07
N/A
Revenue
N/A
N/A
Revenue This Year
$10.36
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$68.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$2.09
52 Week High
$6.02
$3.61

Technical Indicators

Market Signals
Indicator
TACT
XBIT
Relative Strength Index (RSI) 40.17 53.47
Support Level $4.75 $2.30
Resistance Level $6.01 $2.46
Average True Range (ATR) 0.45 0.07
MACD -0.09 0.01
Stochastic Oscillator 14.55 44.00

Price Performance

Historical Comparison
TACT
XBIT

About TACT TransAct Technologies Incorporated

Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: